Patents by Inventor Jae-Hyoung Song

Jae-Hyoung Song has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240092913
    Abstract: The present disclosure relates to an isolated anti-FcRN antibody, which is an antibody binding to FcRN (stands for neonatal Fc receptor, also called FcRP, FcRB or Brambell receptor) that is a receptor with a high affinity for IgG or a fragment thereof, a method of preparing thereof, a composition for treating autoimmune disease, which comprises the antibody, and a method of treating and diagnosing autoimmunre diseases using the antibody. The FcRn-specific antibody according to the present disclosure binds to FcRn non-competitively with IgG to reduce serum pathogenic auto-antibody levels, and thus can be used for the treatment of autoimmune diseases.
    Type: Application
    Filed: November 17, 2023
    Publication date: March 21, 2024
    Applicant: HANALL BIOPHARMA CO., LTD.
    Inventors: Sung Wuk KIM, Seung Kook PARK, Jae Kap JEONG, Hyea Kyung AHN, Min Sun KIM, Eun Sun KIM, Hae-Young YONG, Dongok SHIN, Yeon Jung SONG, Tae Hyoung YOO
  • Patent number: 10092587
    Abstract: The present invention relates to an antiviral composition comprising any one selected from the group consisting of chlorine, phosphocholine, cytidine triphosphate, CDP-choline, phosphorylcholine, and phosphatidylcholine. The antiviral composition is harmless to the human body and exhibits an excellent inhibitory effect on virus proliferation. Therefore, it can be applied to a pharmaceutical composition for preventing or treating viral diseases as well as a health functional food, a quasi-drug composition, and a feed composition for preventing or ameliorating viral diseases.
    Type: Grant
    Filed: December 22, 2016
    Date of Patent: October 9, 2018
    Assignee: KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY
    Inventors: Dur Han Kwon, Mi Jin Jang, Jae Hyoung Song, Gansukh Enkhtaivan, Sei Ryang Oh
  • Publication number: 20170173065
    Abstract: The present invention relates to an antiviral composition comprising any one selected from the group consisting of chlorine, phosphocholine, cytidine triphosphate, CDP-choline, phosphorylcholine, and phosphatidylcholine. The antiviral composition is harmless to the human body and exhibits an excellent inhibitory effect on virus proliferation. Therefore, it can be applied to a pharmaceutical composition for preventing or treating viral diseases as well as a health functional food, a quasi-drug composition, and a feed composition for preventing or ameliorating viral diseases.
    Type: Application
    Filed: December 22, 2016
    Publication date: June 22, 2017
    Applicant: Korea Research Institute of Bioscience and Biotechnology
    Inventors: Dur Han Kwon, Mi Jin Jang, Jae Hyoung Song, Gansukh Enkhtaivan, Sei Ryang Oh
  • Patent number: 9439849
    Abstract: Provided is a composition for preventing or alleviating skin wrinkles containing honeybush (Cyclopia intermedia) extract, a fraction thereof, or a fermented honeybush as an active ingredient. More particularly, the honeybush extract or fermented honeybush of the claimed subject matter can reduce the length and depth of skin wrinkles caused by UV irradiation and reduce the thickness of the epidermal layer, in addition to suppress collagen tissue breakdown reactions, indicating it is excellent in alleviating skin wrinkles, so that it can be effectively used as an active ingredient of a composition for preventing or alleviating skin wrinkles.
    Type: Grant
    Filed: July 11, 2012
    Date of Patent: September 13, 2016
    Assignee: KOREA INSTITUTE OF ORIENTAL MEDICINE
    Inventors: Sungwook Chae, Hwa-Jung Choi, Jae-Hyoung Song, Goya Choi, Mi Young Lee
  • Publication number: 20140127189
    Abstract: Provided is a composition for preventing or alleviating skin wrinkles containing honeybush (Cyclopia intermedia) extract, a fraction thereof, or a fermented honeybush as an active ingredient. More particularly, the honeybush extract or fermented honeybush of the claimed subject matter can reduce the length and depth of skin wrinkles caused by UV irradiation and reduce the thickness of the epidermal layer, in addition to suppress collagen tissue breakdown reactions, indicating it is excellent in alleviating skin wrinkles, so that it can be effectively used as an active ingredient of a composition for preventing or alleviating skin wrinkles.
    Type: Application
    Filed: July 11, 2012
    Publication date: May 8, 2014
    Applicant: KOREA INSTITUTE OF ORIENTAL MEDICINE
    Inventors: Sungwook Chae, Hwa-Jung Choi, Jae-Hyoung Song, Goya Choi, Mi Young Lee